文献速递中医内科中药与中成药合理使用

中药治疗良性前列腺增生的机制与疗效综述

Mechanisms and Efficacy of Chinese Herbal Medicines in Benign Prostatic Hyperplasia.
PubMed 文献 · Chin J Integr Med · 2024-08-27

结果表明中药可能通过调节性激素、下调细胞生长因子、抗炎抗氧化、抑制细胞增殖和促进凋亡等机制发挥作用,并具有类似α受体阻滞剂松弛尿道平滑肌的潜力,初步证据支持其安全性和有效性。

要点

  • 中药治疗BPH涉及多成分、多靶点、多通路机制,包括调节性激素和抗炎抗氧化等。
  • 中药可能具有α受体阻滞剂样作用,松弛尿道平滑肌并缓解下尿路症状。
  • 4项临床试验和荟萃分析提供初步安全性和有效性证据,但需更多高质量研究验证。

核心结论

  • 中药治疗BPH具有多成分、多靶点、多通路优势,可减轻疾病严重程度、改善下尿路症状,未来可能成为可靠治疗选择。

研究设计与样本

  • 主要回顾32篇关于中药及其活性成分治疗BPH的动物和细胞实验论文。
  • 另回顾4项中药治疗BPH患者的临床试验和荟萃分析。

主要发现

  • 中药治疗BPH的机制可能涉及调节性激素、下调细胞生长因子、抗炎抗氧化、抑制细胞增殖和促进凋亡。
  • 中药具有α受体阻滞剂样作用,可能松弛尿道平滑肌并缓解下尿路症状。
  • 4项临床试验和荟萃分析提供中药治疗BPH安全性和有效性的初步证据。

临床怎么用

  • 中药可作为BPH的综合治疗选项之一,尤其关注改善下尿路症状和减轻疾病严重程度。
  • 临床可考虑中药多靶点作用特点,但需结合患者具体情况和现有证据个体化使用。

局限性

  • 综述主要基于动物和细胞实验,临床证据仅来自4项临床试验和荟萃分析,仍需更多高质量研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Benign prostatic hyperplasia (BPH) is one of the most common diseases in elderly men, the incidence of which gradually increases with age and leads to lower urinary tract symptoms (LUTS), which seriously affects the quality of life of patients. Chinese herbal medicines (CHMs) are widely used for the treatment of BPH in China and some other countries. To explore the molecular mechanisms of CHMs for BPH, we conducted a review based on peer-reviewed English-language publications in PubMed and Web of Science databases from inception to December 31, 2023. This article primarily reviewed 32 papers on the use of CHMs and its active compounds in the treatment of BPH, covering animal and cell experiments, and identified relevant mechanisms of action. The results suggest that the mechanisms of action of CHMs in treating BPH may involve the regulation of sex hormones, downregulation of cell growth factors, anti-inflammatory and antioxidative effects, inhibition of cell proliferation, and promotion of apoptosis. CHMs also exhibit α-blocker-like effects, with the potential to relax urethral smooth muscle and alleviate LUTS. Additionally, we also reviewed 4 clinical trials and meta-analyses of CHMs for the treatment of BPH patients, which provided initial evidence of the safety and effectiveness of CHMs treatment. CHMs treatment for BPH shows advantages as a multi-component, multi-target, and multi-pathway therapy, which can mitigate the severity of the disease, improve LUTS, and may become a reliable treatment option in the future.

来源:Chin J Integr Med,查看原文。版权归原作者所有。

引用

  1. Wang F, Ma DY, Yang JT, et al. Mechanisms and Efficacy of Chinese Herbal Medicines in Benign Prostatic Hyperplasia. Chin J Integr Med. 2024. PMID: 39190272. doi:10.1007/s11655-024-3916-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。